Erythroid band 3 variants and disease

Bailliere's Best Practice and Research in Clinical Haematology

Volumn 12, Issue 4, 1999, Pages 637-654

  Bruce, Lesley J ^a   Tanner, Michael J A ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Anion exchanger; Blood group antigen; Glycophorin A; Hereditary spherocytosis; Polymorphism; Red cell membrane; Renal tubular acidosis; Southeast Asian ovalocytosis

Indexed keywords

BLOOD GROUP ANTIGEN; ERYTHROCYTE BAND 3 PROTEIN; GLYCOPHORIN A;

DNA POLYMORPHISM; ELLIPTOCYTOSIS; GENE MUTATION; HEREDITARY SPHEROCYTOSIS; KIDNEY TUBULE ACIDOSIS; PRIORITY JOURNAL; PROTEIN FOLDING; REVIEW;

EID: 0033512949     PISSN: 15216926     EISSN: None     Source Type: Journal    
DOI: 10.1053/beha.1999.0046     Document Type: Article

References (147)

1. Kopito R R. Molecular biology of the anion exchanger gene family. International Reviews of Cytology. 123:1990;177-199.
2. Alper S L. The band 3-related anion exchanger (AE) gene family. Annual Reviews of Physiology. 53:1991;549-564.
3. 3cotransporters: cloning and physiology. Annual Reviews of Physiology. 61:1999;699-723.
4. Richards S M, Jaconi M E, Bassort G, Puceat M. A spliced variant of AE1 gene encodes a truncated form of band 3 in heart: the predominant anion exchanger in ventricular myocytes. Journal of Cell Science. 112:1999;1519-1528.
5. 3exchanger. Journal of Biological Chemistry. 273:1998;28 430-28 437.
6. Lux S E, Palek J. Disorders of the red cell membrane. Handin R I, Lux S E, Stossel T P. Blood: Principles and Practice of Hematology. 1995;1701-1817 JB Lippincott Co, Philadelphia.
7. Delaunay J, Alloisio N, Morle L. Molecular genetics of hereditary elliptocytosis and hereditary spherocytosis. Annales de Genetique. 39:1996;209-221.
8. Tanner M JA. The structure and function of band 3 (AE1): recent developments. Molecular Membrane Biology. 14:1997;155-165.
9. Kay M MB. Band 3 anion transporters in health and disease. Molecular and Cellular Biology. 42:1996;905-1118.
10. Hamasaki N, Mihara K. Membrane Proteins; Structure, Function and Expression Control. 1997;Karger, Basel. p. 317-404.
11. Brown D L, Tenniswood M. Biochemistry and Cell Biology. 76:1998;709-733.
12. Lepke S, Passow H. Effects of incorporated trypsin on anion exchange and membrane proteins in human red blood cell ghosts. Biochimica et Biophysica Acta. 455:1976;353-370.
13. Grinstein S, Ship S, Rothstein A. Anion transport in relation to proteolytic dissection of band 3 protein. Biochimica et Biophysica Acta. 507:1978;294-304.
14. Groves J D, Tanner M JA. Glycophorin A facilitates the expression of human band 3-mediated anion transport in Xenopus oocytes. Journal of Biological Chemistry. 267:1992;22 163-22 170.
15. Lepke S, Becker A, Passow H. Mediation of inorganic anion transport by the hydrophobic domain of mouse erythroid band 3 protein expressed in oocytes of Xenopus laevis. Biochimica et Biophysica Acta. 1106:1992;13-16.
16. Wood P G. The anion exchange proteins: homology and secondary structure. Bamberg E, Passow H. Progress in Cell Research. 1992;325-352 Elsevier, Amsterdam.
17. Reithmeier R AF. The erythrocyte anion transporter (band 3). Current Opinion in Structural Biology. 3:1993;515-523.
18. Tanner M JA. Molecular and cellular biology of the erythrocyte anion exchanger. Seminars in Hematology. 30:1993;34-57.
19. Popov M, Tam L Y, Li J, Reithmeier R AF. Mapping the ends of transmembrane segments in a polytopic membrane protein. Scanning N -glycosylation mutagenesis of extracytosololic loops in the anion exchanger, band 3. Journal of Biological Chemistry. 272:1997;18 325-18 332.
20. Popov M, Li J, Reithmeier R AF. Transmembrane folding of the human erythrocyte anion exchanger (AE1, band 3) determined by scanning and insertional N-glycosylation mutagenesis. Biochemical Journal. 339:1999;269-279.
21. Fujinaga J, Tang X-B, Casey J R. Topology of the membrane domain of the human erythrocyte anion exchange protein, AE1. Journal of Biological Chemistry. 274:1999;6626-6633.
22. Tang X-B, Fujinaga J, Kopito R, Casey J R. Topology of the region surrounding Glu681 of human AE1, the erythrocyte anion exchanger. Journal of Biological Chemistry. 273:1998;22 545-22 553.
23. Tang X-B, Kovacs M, Sterling D, Casey J R. Identification of the translocation pore of human AE1, plasma membrane anion exchange protein. Journal of Biological Chemistry. 274:1999;3557-3564.
24. Wang D N, Kuhlbrandt W, Sarabia V E, Reithmeier R AF. Two dimensional structure of the membrane domain of human band 3, the anion transport protein of the erythrocyte membrane. European Molecular Biology Association Journal. 12:1993;2233-2239.
25. Wang D N, Sarabia V E, Reithmeier R AF, Kuhlbrandt W. Three-dimensional map of the dimeric membrane domain of the human erythrocyte anion exchanger, band 3. European Molecular Biology Association Journal. 13:1994;3230-3235.
26. Gargaro A R, Bloomberg G B, Dempsey C E. The solution structures of the first and second transmembrane-spanning segments of band 3. European Journal of Biochemistry. 221:1994;445-454.
27. Chambers E J, Bloomberg G B, Ring S M, Tanner M JA. Structural studies on the effects of the deletion in the red cell anion exchanger (band 3, AE1) associated with Southeast Asian Ovalocytosis. Journal of Molecular Biology. 285:1999;1289-1307.
28. Askin D, Bloomberg G B, Chambers E J, Tanner M JA. NMR solution structure of a cytoplasmic surface loop of the human red cell anion transporter, band 3. Biochemistry. 37:1998;11 670-11 678.
29. Groves J D, Tanner M JA. Co-expressed fragments of the human red cell anion exchanger (band 3; AE1) generate stilbene disulfonate sensitive anion transport. Journal of Biological Chemistry. 270:1995;9097-9105.
30. Wang L, Groves J D, Mawby W J, Tanner M JA. Complementation studies with co-expressed fragments of the human red cell anion transporter (band 3; AE1): role of some exofacial loops in anion transport. Journal of Biological Chemistry. 272:1997;10 631-10 638.
31. Groves J D, Wang L, Tanner M JA. Complementation studies with co-expressed fragments of human red cell band 3 (AE1): the assembly of the anion transport domain in Xenopus oocytes and a cell-free translation system. Biochemical Journal. 332:1998;161-171.
32. Groves J D, Wang L, Tanner M JA. Functional reassembly of the anion transport domain of human red cell band 3 (AE1) from multiple and non-complementary fragments. Federation of European Biochemical Societies Letters. 433:1998;223-227.
33. Ota K, Sakaguchi M, von Heijne G. Forced transmembrane orientation of hydrophilic polypeptide segments in multispanning membrane proteins. Molecular Cell. 2:1998;495-503.
34. Ota K, Sakaguchi M, Hamasaki N, Mihara K. Assessment of topogenic functions of anticipated transmembrane segments of human band 3. Journal of Biological Chemistry. 273:1998;28 286-28 291.
35. Groves J D, Tanner M JA. Topology studies with biosynthetic fragments identify interacting transmembrane regions of the human red cell anion exchanger (band 3; AE1). Biochemical Journal. 344:1999;687-697.
36. Hamasaki N, Okubo K, Kuma H. Proteolytic cleavage sites of band 3 protein in alkali treated membranes: fidelity of hydropathy predictions for band 3 protein. Journal of Biochemistry (Tokyo). 122:1997;577-585.
37. Groves J D, Tanner M JA. A structural model for the organisation of the transmembrane spans of the human red cell anion exchanger (band 3; AE1). Biochemical Journal. 344:1999;699-711.
38. Schofield A E, Martin P G, Spillett D, Tanner M JA. The structure of the human red blood cell anion exchanger (EPB3, AE1, band 3) gene. Blood. 84:1994;2000-2012.
39. Sahr K E, Taylor W M, Daniels B P. The structure and organisation of the human erythroid anion exchanger (AE1) gene. Genomics. 24:1994;491-501.
40. 2terminus. American Journal of Physiology. 265:1993;F813-F821.
41. Amato D, Booth P B. Hereditary ovalocytosis in Melanesians. Papua New Guinea Medical Journal. 20:1977;26-32.
42. Schofield A E, Rearden D M, Tanner M JA. Defective anion transport activity of the abnormal band 3 in hereditary ovalocytic red blood cells. Nature, London. 355:1992;836-838.
43. Ravindranath Y, Goyette G Jr, Johnson R M. Southeast Asian ovalocytosis in an African-American family. Blood. 84:1994;2823-2824.
44. Coetzer T, Beeton L, Van Zyl D. Southeast Asian ovalocytosis in a South African kindred with hemolytic anemia. Blood. 87:1996;1656-1657.
45. Schischmanoff P O, Cynober T, Mielot F. Southeast Asian ovalocytosis in White persons. Hemoglobin. 23:1999;47-56.
46. Tanner M JA, Bruce L J, Martin P G. Melanesian hereditary ovalocytes have a deletion in red cell band 3. Blood. 78:1991;2785-2787.
47. Jarolim P, Palek J, Amato D. Deletion in erythrocyte band 3 gene in malaria-resistant southeast Asian ovalocytosis. Proceedings of the National Academy of Sciences of the USA. 78:1991;11 022-11 026.
48. Mohandas N, Winardi R, Knowles D. Molecular basis of membrane rigidity of hereditary ovalocytosis. A novel mechanism involving the cytoplasmic domain of band 3. Journal of Clinical Investigation. 89:1992;686-692.
49. Mohandas N, Lie-Injo L E, Friedman M, Mak J W. Rigid membranes of Malayan ovalocytes: a likely genetic barrier against malaria. Blood. 63:1984;1385-1392.
50. Saul A, Lamont G, Sawyer W H, Kidson C. Decreased membrane deformability in Melanesian ovalocytes from Papua New Guinea. Journal of Cell Biology. 98:1984;1348-1454.
51. Schofield A E, Tanner M JA, Pinder J C. Basis of unique red cell membrane properties in hereditary ovalocytosis. Journal of Molecular Biology. 223:1992;949-958.
52. Moriyama R, Ideguchi H, Lombardo C R. Structural and functional characterisation of band 3 from southeast Asian ovalocytes. Journal of Biological Chemistry. 267:1992;25 792-25 797.
53. Liu S-C, Palek J, Yi S J. Molecular basis of altered red blood cell membrane properties in southeast Asian ovalocytosis: role of the mutant band 3 protein in band 3 oligomerization and retention by the membrane skeleton. Blood. 86:1995;349-358.
54. Cattani J A, Gibson F D, Alpers M P, Crane G G. Hereditary ovalocytosis and reduced susceptibility to malaria in Papua New Guinea. Transactions of the Royal Society of Tropical Medicine and Hygiene. 81:1987;705-709.
55. Dluzewski A R, Nash G B, Wilson R JM. Invasion of hereditary ovalocytes by Plasmodium falciparum in vitro and its relation to intracellular ATP concentration. Molecular Biochemistry and Parasitology. 55:1992;1-8.
56. Bruce L J, Ring S M, Ridgwell K. South-east Asian ovalocytic (SAO) erythrocytes have a cold sensitive cation leak: implications for in vitro studies on stored SAO red cells. Biochimica et Biophysica Acta. 1416:1998;258-270.
57. Genton B, Al-Yaman F, Mgone C S. Ovalocytosis and cerebral malaria. Nature, London. 378:1995;564-565.
58. Allen S J, O'Donnell A, Alexander N D. Prevention of cerebral malaria in children in Papua New Guinea by southeast Asian ovalocytosis band 3. American Journal of Tropical Medicine and Hygiene. 60:1999;1056-1060.
59. Sarabia V E, Casey J R, Reithmeier R AF. Molecular characterization of the band 3 protein from southeast Asian ovalocytes. Journal of Biological Chemistry. 268:1993;10 676-10 680.
60. Groves J D, Ring S M, Schofield A E, Tanner M JA. The expression of the abnormal human red cell anion transporter from south-east Asian ovalocytes (band 3SAO) in Xenopus oocytes. Federation of European Biochemical Societies Letters. 330:1993;186-190.
61. Che A, Cherry R J, Bannister L H, Dluzewski A R. Aggregation of band 3 in hereditary ovalocytic red blood cell membranes. Electron microscopy and protein rotational diffusion studies. Journal of Cell Science. 105:1993;655-660.
62. Booth P B, Serjeantson S, Woodfield D G, Amato D. Selective depression of blood group antigens associated with hereditary ovalocytosis among Melanesians. Vox Sanguinis. 32:1977;99-110.
63. Smythe J S, Spring F A, Gardner B. Monoclonal antibodies recognizing epitopes on the extracellular face and intracellular N-terminus of the human erythrocyte anion transporter (band 3) and their application to the analysis of south east Asian ovalocytes. Blood. 85:1995;2929-2936.
64. Jennings M L, Gosselink P G. Anion exchange protein in southeast Asian ovalocytes: heterodimer formation between normal and variant subunits. Biochemistry. 34:1995;3588-3595.
65. Salhany J M, Schopfer L M. Interactions between mutant and wild-type band 3 subunits in hereditary southeast Asian ovalocytic red blood cell membranes. Biochemistry. 35:1996;251-257.
66. Liu S-C, Jarolim P, Rubin H L. The homozygous state for the band 3 protein mutation in southeast Asian ovalocytosis may be lethal. Blood. 84:1994;3590-3591.
67. Becker P S, Lux S E. Hereditary spherocytosis and hereditary elliptocytosis. Schriver C R, Baeudet A L, Sly W S, Valle D. The Metabolic and Molecular Bases of Inherited Diseases. 1994;3513-3560 McGraw-Hill Inc. New York.
68. Benz E J Jr. The erythrocyte membrane and cytoskeleton: structure, function and disorders. Stamatoyannopoulos G, Nienhuis A W, Majerus P W, Varmus H. The Molecular Basis of Blood Diseases. 1994;257-292 W.B. Saunders Co. Philadelphia.
69. Hassoun H, Palek J. Hereditary spherocytosis: a review of the clinical and molecular aspects of the disease. Blood Reviews. 10:1996;129-147.
70. Gallagher P G, Forget B G. Hematologically important mutations: band 3 and protein 4·2 variants in hereditary spherocytosis. Blood Cells, Molecules and Diseases. 23:1997;417-421.
71. Tse W T, Lux S E. Red blood cell membranes disorders. British Journal of Haematology. 104:1999;2-13.
72. Montefiore). Blood. 81:1993;2155-2165.
73. Eber S W, Gonzalez J M, Lux M L. Ankyrin-1 mutations are a major cause of dominant and recessive hereditary spherocytosis. Nature Genetics. 13:1996;214-218.
74. Inoue T, Kanzaki A, Kaku M. Homozygous missense mutation (band 3 Fukuoka: G130R): a mild form of hereditary spherocytosis with near-normal band 3 content and minimal changes of membrane ultrastructure despite moderate protein 4·2 deficiency. British Journal of Haematology. 102:1998;932-939.
75. Kanzaki A, Hayette S, Morle L. Total absence of protein 4·2 and partial deficiency of band 3 in hereditary spherocytosis. British Journal of Haematology. 99:1997;522-530.
76. 327substitution in the cytoplasmic domain of erythrocyte band 3 protein associated with spherocytic hemolytic anemia and partial deficiency of protein 4·2. Blood. 80:1992;523-529.
77. Jarolim P, Murray J L, Rubin H L. Characterization of 13 novel band 3 gene defects in hereditary spherocytosis with band 3 deficiency. Blood. 88:1996;4366-4374.
78. Alloisio N, Maillet P, Carre G. Hereditary spherocytosis with band 3 deficiency. Association with a nonsense mutation of band 3 gene (allele Lyon), and aggravation by a low expression allele occurring in trans (allele Genas). Blood. 88:1996;1062-1069.
79. Perrotta S, Nigro V, Iolascon A. Dominant hereditary spherocytosis due to band 3 Neapolis produces a life-threatening anemia at the homozygous state. Blood. 92:1998;9a.
80. Kanzaki A, Takezono M, Kaku M. Molecular and genetic characteristics in Japanese patients with hereditary spherocytosis: frequent band 3 mutations and rarer ankyrin mutations. Blood. 90:1997;6b.
81. Miraglia del Giudice E, Vallier A, Maillet P. Novel band 3 variants (band 3 Foggia, Napoli I and Napoli II) associated with hereditary spherocytosis and band 3 deficiency: state of the D38A polymorphism within the EPB3 locus. British Journal of Haematology. 96:1997;70-76.
82. Dhermy D, Galand C, Bournier O. Heterogenous band 3 deficiency in hereditary spherocytosis related to different band 3 gene defects. British Journal of Haematology. 98:1997;32-40.
83. +countertransport and an abnormal renal biocarbonate handling. Blood. 90:1997;2810-2818.
84. Jenkins P B, Abou-Alfa G K, Dhermy D. A nonsense mutation in the erythrocyte band 3 gene associated with decreased mRNA accumulation in a kindred with dominant hereditary spherocytosis. Journal of Clinical Investigation. 97:1996;373-380.
85. Alloisio N, Texier P, Vallier A. Modulation of clinical expression and band 3 deficiency in hereditary spherocytosis. Blood. 90:1997;414-420.
86. Bianchi P, Zanella A, Alloisio N. A variant of the EPB3 gene of the anti-Lepore type in hereditary spherocytosis. British Journal of Haematology. 98:1995;283-288.
87. Jarolim P, Rubin H L, Brabec V. Mutations of conserved arginines in the membrane domain of erythroid band 3 lead to a decrease in membrane-associated band 3 and to the phenotype of hereditary spherocytosis. Blood. 85:1995;634-640.
88. Maillet P, Vallier A, Reinhart W H. Band 3 Chur: a variant associated with band 3-deficient hereditary spherocytosis and substitution in a highly conserved position of transmembrane segment 11. British Journal of Haematology. 91:1995;804-810.
89. Prague). Journal of Clinical Investigation. 93:1994;121-130.
90. Iwase S, Ideguchi H, Takao M. Band 3 Tokyo: Thr837→Ala837 substitution in erythrocyte band 3 protein associated with spherocytic hemolysis. Acta Haematologica. 100:1999;200-203.
91. Perrotta S, Polito R, Conte M L. Hereditary spherocytosis due to a novel frameshift mutation in AE1 cytoplasmic COOH terminal tail: band 3 Vesuvio. Blood. 93:1999;2131-2132.
92. Tanner M JA, Martin P G, High S. The complete amino acid sequence of the human erythrocyte membrane anion-transport protein deduced from the cDNA. Biochemical Journal. 256:1988;703-712.
93. Rybicki A C, Musto S, Schwartz R S. Identification of a band-3 binding site near the N-terminus of erythrocyte membrane protein 4·2. Biochemical Journal. 309:1995;677-681.
94. Miraglia del Giudice E, Perrotta S, Nobili B. Coexistence of hereditary spherocytosis (HS) due to band 3 deficiency and β-thalassaemia trait: partial correction of HS phenotype. British Journal of Haematology. 85:1993;553-557.
95. Ribeiro M L, Alloisio N, Almeida H. Hereditary spherocytosis with total absence of band 3 in a baby with mutation Coimbra (V488M) in the homozygous state. Blood. 90:1997;265a.
96. Peters L L, Shivdasani R A, Liu S-C. Anion exchanger 1 (band 3) is required to prevent erythrocyte membrane surface loss but not to form the membrane skeleton. Cell. 86:1996;917-927.
97. Hassoun H, Hanada T, Lutchman M. Complete deficiency of glycophorin A in red blood cells from mice with targeted inactivation of the band 3 (AE1) gene. Blood. 91:1998;2146-2151.
98. Inaba M, Yawata A, Koshino I. Defective anion transport and marked spherocytosis with membrane instability caused by hereditary total deficiency of red cell band 3 in cattle due to a nonsense mutation. Journal of Clinical Investigation. 97:1996;1804-1817.
99. Bruce L J, Kay M MB, Lawrence C, Tanner M JA. Band 3 HT, a human red-cell variant associated with acanthocytosis and increased anion transport, carries the mutation Pro-868 > Leu in the membrane domain of band 3. Biochemical Journal. 293:1993;317-320.
100. Salhany J M, Schopfer L M, Kay M MB. Differential sensitivity of stilbene disulfonates in their reaction with band 3 HT (Pro-868→Leu). Proceedings of the National Academy of Sciences of the USA. 92:1995;11 844-11 848.
101. Kay M MB, Bosman G JCGM, Lawrence C. Functional topography of band 3: specific structural alteration linked to functional aberrations in human erythrocytes. Proceedings of the National Academy of Sciences of the USA. 85:1988;492-496.
102. Gomez S, Morgans C. Interaction between band 3 and ankyrin begins in early compartments of the secretory pathway and is essential for band 3 processing. Journal of Biological Chemistry. 268:1993;19 593-19 597.
103. Ranney H M, Rosenberg G H, Morrison M. Frequencies of band 3 variants of human red cell membranes in some different populations. British Journal of Haematology. 76:1990;262-267.
104. Yannoukakos D, Vasseur C, Draincourt C. Human erythrocyte band 3 polymorphism (band 3 Memphis): characterisation of the structural modification (Lys56→Glu) by protein chemistry methods. Blood. 78:1991;1117-1120.
105. Jarolim P, Rubin H L, Zhai S. Band 3 Memphis: a widespread polymorphism with abnormal electrophoretic mobility of erythrocyte band 3 protein caused by substitution AAG-GAG (Lys-Glu) in codon 56. Blood. 80:1992;1592-1598.
106. Ideguchi H, Okubo K, Ishikawa A. Band 3-Memphis is associated with a lower transport rate of phosphoenolpyruvate. British Journal of Haematology. 82:1992;122-125.
107. Mueller T J, Morrison M. Detection of a variant of protein 3, the major transmembrane protein of the human erythrocyte. Journal of Biological Chemistry. 252:1977;6573-6578.
108. Hsu L, Harrison M. A new variant of the anion transport protein in human erythrocytes. Biochemistry. 24:1985;3086-3090.
109. a) blood group antigen. Biochemical Journal. 288:1992;713-716.
110. Mourant A E, Kopec A C, Domaniewska-Sobczak K. The Distribution of the Human Blood Groups and other Polymorphisms. 1976;Oxford University Press, London. p. 20-24.
111. Race R R, Sanger R. Blood Groups in Man. 1975;Blackwell, Oxford. p. 372-378.
112. aantigen in Poland. Vox Sanguinis. 62:1992;124-126.
113. a) blood group antigen are associated with the human erythrocyte band 3 mutation Pro854→Leu. Journal of Biological Chemistry. 269:1994;16 155-16 158.
114. Salhany J M, Sloan R L, Schopfer L M. Characterisation of the stilbene disulphonate binding site on band 3 Memphis variant II (Pro854→Leu). Biochemical Journal. 317:1996;509-514.
115. Gahmberg C G, Myllyla G, Liekola J. Absence of the major sialoglycoprotein in the membrane of human En(a-) erythrocytes and increased glycosylation of band 3. Journal of Biological Chemistry. 251:1976;6108-6116.
116. Tanner M JA, Jenkins R E, Anstee D J, Clamp J R. Abnormal carbohydrate composition of the major membrane-penetrating protein of En(a-) human erythrocytes. Biochemistry Journal. 155:1976;701-703.
117. k) red blood cells. Blood. 84:1994;916-922.
118. Nigg E A, Bron E A, Girardet M, Cherry R J. Band 3-glycophorin A association in erythrocyte membrane demonstrated by combining protein diffusion measurements with antibody-induced crosslinking. Biochemistry. 19:1980;1887-1893.
119. Che A, Cherry R J. Loss of rotational mobility of band 3 proteins in human erythrocyte membranes induced by antibodies to glycophorin A. Biophysical Journal. 68:1995;1881-1887.
120. Paulitschke M, Nash G B, Anstee D J. Perturbation of red blood cell membrane rigidity by extracellular ligands. Blood. 86:1995;342-348.
121. bantigen to an interaction between glycophorin A and band 3. Blood. 76:1990;842-848.
122. bred cell antigens. Vox Sanguinis. 67:1994;226-230.
123. a). Lancet. 2:1953;119-120.
124. Adams J, Broviac M, Brooks W. An antibody in the serum of a Wr(a+) individual, reacting with an antigen of very high frequency. Transfusion. 11:1971;290-291.
125. Dahr W, Schutt K H, Arnt-Haner A. A novel phenotype within the Wright blood group collection. Transfusion. 32:1992;55s.
126. a-positive and Dantu-positive human erythrocytes. Journal of Immunogenetics. 11:1984;365-370.
127. Bruce L J, Ring S M, Anstee D J. Changes in the blood group Wright antigens are associated with a mutation at amino acid 658 in human erythrocyte band 3: a site of interaction between band 3 and glycophorin A under certain conditions. Blood. 85:1995;541-547.
128. Poole J, Banks J A, Bruce L J. Glycophorin A mutation Ala 65→Pro gives rise to a novel pair of MNS alleles ENEP (MNS39) and HAG (MNS41) and altered wrb expression: direct evidence for GPA/band 3 interaction necessary for normal wrb expression. Transfusion Medicine. 9:1999;167-174.
129. Jarolim P, Moulds J M, Moulds J J. MARS and AVIS blood group antigens: polymorphism of glycophorin A affects band 3-glycophorin A interaction. Blood. 88:1996;182a.
130. Zelinski T, Punter F, McManus K, Coghlan G. The ELO blood group polymorphism is located in the putative first extracellular loop of human erythrocyte band 3. Vox Sanguinis. 75:1998;63-65.
131. Jarolim P, Rubin H L, Zakova D. Characterization of seven low incidence blood group antigens carried by erythrocyte band 3 protein. Blood. 92:1998;4836-4843.
132. Jarolim P, Murray J L, Rubin H L. Blood group antigens Rb(a), Tr(a) and Wd(a) are located in the third ectoplasmic loop of erythroid band 3. Transfusion. 37:1997;607-615.
133. Jarolim P, Murray J L, Rubin H L. A Thr522→Ile substitution in erythroid band 3 gives rise to the Warrior blood group antigen. Transfusion. 37:1997;398-405.
134. a, is associated with the substitution Val557→Met in human erythrocyte band 3 (AE1). Vox Sanguinis. 71:1996;118-120.
135. McManus K, Coghlan G, Zelinski T. Substitutions in erythrocyte membrane protein, band 3, underlie the BOW and NFLD blood group polymorphisms. Transfusion. 38:1998;102s.
136. Zelinski T, McManus K, Punter F. A Gly565→Ala substitution in human erythroid band 3 accounts for the Wu blood group polymorphism. Transfusion. 38:1998;745-748.
137. ato erythrocyte band 3. Transfusion. 37:1997;90s.
138. Zelinski T, Rusnak A, McManus K, Coghlan G. A G→A mutation in the anion exchanger 1 gene (AE1) accounts for the Swann blood group polymorphism. Transfusion. 37:1997;89s.
139. Morris R C, Ives H E. Inherited disorders of the renal tubule. Brenner B M. The Kidney. 1996;1764-1827 WB Saunders, Philadelphia.
140. Wrong O, Unwin R, Cohen E. Unravelling of the molecular mechanism of kidney stones. Lancet. 348:1996;1561-1565.
141. Alpern R J, Rector F C. Renal acidification: cellular mechanisms of tubular transport and regulation. Windhager E E. Handbook of Physiology: Section 8, Renal Physiology. 1992;767-812 Oxford University Press, Oxford.
142. Tanner M JA. The acid test for band 3. Nature, London. 382:1996;209-210.
143. Bruce L J, Cope D L, Jones G K. Familial distal renal tubular acidosis is associated with mutations in the red cell anion exchanger (band 3,AE1 ) gene. Journal of Clinical Investigation. 100:1997;1693-1707.
144. Karet F E, Gainza F J, Gyory A Z. Mutations in the chloride-bicarbonate exchanger gene AE1 cause autosomal dominant but not autosomal recessive distal renal tubular acidosis. Proceedings of the National Academy of Sciences of the USA. 95:1998;6337-6342.
145. 3exchanger. Journal of Biological Chemistry. 273:1998;6380-6388.
146. +-ATPase cause renal tubular acidosis with sensorineural deafness. Nature Genetics. 21:1999;84-90.
147. Tanphaichitr V S, Sumboonnanonda A, Ideguchi H. Novel AE1 mutations in recessive distal renal tubular acidosis. Journal of Clinical Investigation. 102:1998;2173-2179.